$
DRIO
: DarioHealth Awarded U.S. Patent for Optical Transmission of Data Between a Sensor and Smart Device
8:00 AM ET 9/18/19 | PR Newswire
- U.S. patent supports the development and implementation of paired smartphone devices to collect and analyze real-time medical data
NEW YORK and CAESAREA, Israel, Sept. 18, 2019 /PRNewswire/ -- DarioHealth Corp. ("DarioHealth" or "Dario"
(Nasdaq: DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled "Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device." The patent will allow Dario to develop paired smartphone devices that can collect and analyze real-time medical data and provide immediate and highly detailed, personalized data reports to the user. Once collected, this data can be shared with healthcare providers through the DarioEngage(TM) platform to facilitate digital health interventions based on the data analysis.
"Dario's business and product strategy is guided by evidence that shows that increased user engagement and direct empowerment of individuals to manage their personal health leads to better medical outcomes," said Erez Raphael, DarioHealth's chief executive officer. "As a result, our product innovation has continually focused on enhancing Dario's user experience and developing new ways to integrate intelligent, medical device technology with the smartphone to make health and chronic condition management easy, affordable and convenient."
DarioHealth's digital therapeutics solutions are unique in that they capture and analyze members' real-time, clinical data using a member's smartphone and allow for full access and connectivity to that data at any time throughout the day, along with personalized daily and weekly health data reports. This provides Dario members a fully personalized, integrated and exceptionally convenient platform to manage their health throughout the day, and facilitates a heightened user experience, increased user engagement and improved clinical health outcomes.
As the future of healthcare becomes increasingly digitized and focused on empowering individuals to take control of their personal health, DarioHealth believes smartphones will serve as the primary conduit for health interventions and chronic condition management.
As a pioneer in the digital therapeutics industry, DarioHealth supports the evolution of iOS and Android mobile devices and continually seeks opportunities to use smartphones as the primary health management device, integrated with connected medical devices, rather than requiring users to purchase and use a secondary device that has to synchronize information with a smartphone, which is less convenient, effective and efficient.
DarioHealth plans to begin development of new paired smartphone medical devices in the coming year, which will further advance the company's objective of providing highly effective, inexpensive and convenient digital therapeutic health solutions that empower individuals to best manage their chronic health conditions and improve their overall health.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, we empower individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Our cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario(TM) mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease. To learn more about DarioHealth and its digital health solutions, please go to: http://mydario.com/
8:00 AM ET 9/18/19 | PR Newswire
- U.S. patent supports the development and implementation of paired smartphone devices to collect and analyze real-time medical data
NEW YORK and CAESAREA, Israel, Sept. 18, 2019 /PRNewswire/ -- DarioHealth Corp. ("DarioHealth" or "Dario"
(Nasdaq: DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled "Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device." The patent will allow Dario to develop paired smartphone devices that can collect and analyze real-time medical data and provide immediate and highly detailed, personalized data reports to the user. Once collected, this data can be shared with healthcare providers through the DarioEngage(TM) platform to facilitate digital health interventions based on the data analysis. "Dario's business and product strategy is guided by evidence that shows that increased user engagement and direct empowerment of individuals to manage their personal health leads to better medical outcomes," said Erez Raphael, DarioHealth's chief executive officer. "As a result, our product innovation has continually focused on enhancing Dario's user experience and developing new ways to integrate intelligent, medical device technology with the smartphone to make health and chronic condition management easy, affordable and convenient."
DarioHealth's digital therapeutics solutions are unique in that they capture and analyze members' real-time, clinical data using a member's smartphone and allow for full access and connectivity to that data at any time throughout the day, along with personalized daily and weekly health data reports. This provides Dario members a fully personalized, integrated and exceptionally convenient platform to manage their health throughout the day, and facilitates a heightened user experience, increased user engagement and improved clinical health outcomes.
As the future of healthcare becomes increasingly digitized and focused on empowering individuals to take control of their personal health, DarioHealth believes smartphones will serve as the primary conduit for health interventions and chronic condition management.
As a pioneer in the digital therapeutics industry, DarioHealth supports the evolution of iOS and Android mobile devices and continually seeks opportunities to use smartphones as the primary health management device, integrated with connected medical devices, rather than requiring users to purchase and use a secondary device that has to synchronize information with a smartphone, which is less convenient, effective and efficient.
DarioHealth plans to begin development of new paired smartphone medical devices in the coming year, which will further advance the company's objective of providing highly effective, inexpensive and convenient digital therapeutic health solutions that empower individuals to best manage their chronic health conditions and improve their overall health.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, we empower individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Our cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario(TM) mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease. To learn more about DarioHealth and its digital health solutions, please go to: http://mydario.com/
What I post is my opinion. Do your own DD. Make your own investment decision. Links, images, & retweets are not endorsements.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
4️⃣Not Financial Advice. What I post is my opinion.
Also Paid for Advertising/IR/PR on Emerging Companies
Full Disclaimer: https://corporateads.com/disclaimer/
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
4️⃣Not Financial Advice. What I post is my opinion.
Also Paid for Advertising/IR/PR on Emerging Companies
Full Disclaimer: https://corporateads.com/disclaimer/
